BlackRock
SNTI icon

BlackRock’s Senti Biosciences Holdings SNTI Stock Holding History

BlackRock’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.4K Buy
25,074
+1,690
+7% +$1.64K ﹤0.01% 5299
2025
Q4 		$24.3K Buy
23,384
+780
+3% +$1.38K ﹤0.01% 5181
2025
Q3 		$31.9K Buy
22,604
+520
+2% +$869 ﹤0.01% 5061
2025
Q2 		$46.6K Buy
22,084
+18,080
+452% +$57.2K ﹤0.01% 5000
2025
Q1 		$13.5K Hold
4,004
– – ﹤0.01% 5141
2024
Q4 		$14.1K Hold
4,004
– – ﹤0.01% 5144
2024
Q3 		$9.05K Sell
4,004
-1
-0% -$3 ﹤0.01% 4989
2024
Q2 		$11.1K Hold
4,005
– – ﹤0.01% 5061
2024
Q1 		$15.1K Hold
4,005
– – ﹤0.01% 5051
2023
Q4 		$26.4K Hold
4,005
– – ﹤0.01% 5050
2023
Q3 		$16.5K Hold
4,005
– – ﹤0.01% 5164
2023
Q2 		$25.1K Hold
4,005
– – ﹤0.01% 5176
2023
Q1 		$47.3K Hold
4,005
– – ﹤0.01% 5132
2022
Q4 		$56.5K Buy
4,005
+3,742
+1,423% +$91.3K ﹤0.01% 5194
2022
Q3 		$6K Buy
+263
New +$5.18K ﹤0.01% 5623

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

BlackRock's SNTI Position: Q1 2026 in Review

BlackRock increased its Senti Biosciences Holdings (SNTI) stake by 7.2% in Q1 2026, buying an estimated $1.64K and bringing the position to 25,074 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5299.

BlackRock first reported a position in SNTI in Q3 2022 and has held it in 15 quarters since. The position peaked at $56.5K in Q4 2022. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • BlackRock held 25,074 shares of Senti Biosciences Holdings worth $20.4K as of Q1 2026.
  • BlackRock bought 1,690 Senti Biosciences Holdings shares in Q1 2026, an estimated $1.64K.
  • Senti Biosciences Holdings made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5299 holding.
  • BlackRock first reported a position in Senti Biosciences Holdings in Q3 2022 and has held it in 15 quarters since.
  • BlackRock's Senti Biosciences Holdings position peaked at $56.5K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.